Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Lowdell

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation modelJonathan M Fishman, Mark W Lowdell, Luca Urbani, et al.
Scientific Reports|August 12, 2017
Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imagingRoxanne Hachani, Martin A Birchall, Mark W Lowdell, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapyHelena Arellano-Ballestero, Agnieszka Zubiak, Chris Dally, et al.
Molecular Therapy. Methods & Clinical Development|January 15, 2025
Increased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection systemAine O'Sullivan, Sarah Case, Aisling McCrudden, et al.
Journal of Molecular Biology|July 29, 2008
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virusHeide Kogelberg, Berend Tolner, Gareth J Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 30, 2018
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid LeukemiaTodd A Fehniger, Jeffrey S Miller, Robert K Stuart, et al.
Tissue Engineering. Part A|November 13, 2015
Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case SeriesEmily J Culme-Seymour, Katrina Mason, Laura Vallejo-Torres, et al.
Blood|June 12, 2009
2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cellsAndrew J Steele, Archibald G Prentice, A Victor Hoffbrand, et al.
Cytotherapy|December 2, 2020
Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxiaNicola J Robertson, Christopher Meehan, Kathryn A Martinello, et al.
Cytotherapy|August 19, 2025
Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseasesLindsay C Davies, Lucie Biard, Damián García-Olmo, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation modelJonathan M Fishman, Mark W Lowdell, Luca Urbani, et al.
Scientific Reports|August 12, 2017
Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imagingRoxanne Hachani, Martin A Birchall, Mark W Lowdell, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapyHelena Arellano-Ballestero, Agnieszka Zubiak, Chris Dally, et al.
Molecular Therapy. Methods & Clinical Development|January 15, 2025
Increased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection systemAine O'Sullivan, Sarah Case, Aisling McCrudden, et al.
Journal of Molecular Biology|July 29, 2008
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virusHeide Kogelberg, Berend Tolner, Gareth J Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 30, 2018
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid LeukemiaTodd A Fehniger, Jeffrey S Miller, Robert K Stuart, et al.
Tissue Engineering. Part A|November 13, 2015
Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case SeriesEmily J Culme-Seymour, Katrina Mason, Laura Vallejo-Torres, et al.
Blood|June 12, 2009
2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cellsAndrew J Steele, Archibald G Prentice, A Victor Hoffbrand, et al.
Cytotherapy|December 2, 2020
Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxiaNicola J Robertson, Christopher Meehan, Kathryn A Martinello, et al.
Cytotherapy|August 19, 2025
Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseasesLindsay C Davies, Lucie Biard, Damián García-Olmo, et al.
Pageof 8